Inhibition of amyloid fibrillogenesis and toxicity by a peptide chaperone

Author： Santhoshkumar Puttur Sharma Krishna K.

ISSN： 0300-8177

Source： Molecular and Cellular Biochemistry, Vol.267, Iss.1-2, 2004-12, pp. : 147-155

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Design of Peptide-based Inhibitors of Human Islet Amyloid Polypeptide Fibrillogenesis

By Scrocchi L.A. Chen Y. Waschuk S. Wang F. Cheung S. Darabie A.A. McLaurin J. Fraser P.E.

Journal of Molecular Biology, Vol. 318, Iss. 3, 2002-05 ,pp. : 697-706

Academic Press

Access to resources Recommend Favorite

Identification and Characterization of Key Kinetic Intermediates in Amyloid &bgr;-protein Fibrillogenesis

By Kirkitadze M.D. Condron M.M. Teplow D.B.

Journal of Molecular Biology, Vol. 312, Iss. 5, 2001-10 ,pp. : 1103-1119

Academic Press

Access to resources Recommend Favorite

Inhibitors of islet amyloid polypeptide fibrillogenesis, and the treatment of type-2 diabetes

By Louise A. Scrocchi

Letters in Peptide Science, Vol. 10, Iss. 5, 2003-01 ,pp. : 545-551

Springer Publishing Company

Access to resources Recommend Favorite

Methionine oxidation: Implications for the mechanism of toxicity of the -amyloid peptide from Alzheimers disease

By Giuseppe D. Ciccotosto

Letters in Peptide Science, Vol. 10, Iss. 5, 2003-01 ,pp. : 413-417

Springer Publishing Company

Access to resources Recommend Favorite

Sub-lethal levels of amyloid β-peptide oligomers decrease non-transferrin-bound iron uptake and do not potentiate iron toxicity in primary hippocampal neurons

By SanMartín C.

BioMetals, Vol. 25, Iss. 4, 2012-08 ,pp. : 805-813

Springer Publishing Company

Access to resources Recommend Favorite